mskcc.org5d
Digging Into a Decades-Old Hepatitis B Mystery Suggests a New Potential Treatment
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
mskcc.org6d
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumor (TGCT)
The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...
mskcc.org6d
In Early-Phase Pancreatic Cancer Clinical Trial, Investigational mRNA Vaccine Induces Sustained Immune Activity in Small Patient Group
Dr. Vinod Balachandran says mRNA vaccines could stimulate the immune system to recognize and attack pancreatic cancer cells. An experimental approach to treating pancreatic cancer with the messenger ...
mskcc.org6d
The Naama Aviram Lab
The Aviram Lab investigates the molecular mechanisms that protect microorganisms from their own pathogenic invaders.
mskcc.org6d
Characterizing Germline Cancer Mechanisms at Scale: Risk, Tumor Evolution, and Treatment Outcomes
Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
mskcc.org6d
Building Cellular Memories as a Mechanism of Therapy Resistance in Melanoma
Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
mskcc.org5d
Genome Organization of T Cells
This seminar is open to the research community.
mskcc.org6d
Naama Aviram: Publications
Aviram N*^, Shilton AK*, Reis BS, Brivanlou A, Marraffini LA^ (2024). Cas10 relieves host growth arrest to facilitate spacer retention during type III-A CRISPR-Cas immunity. Cell Host & Microbe (In ...
mskcc.org5d
Transcription and the Mechanism of Somatic Hypermutation
Tea will be served at 1:15 p.m., immediately preceding the seminar.